How many patents does
Heptares Therapeutics have?
patents
470
families
59
granted
92
applications
378
US
89
GB
72
WO
49
EP
44
JP
37
CN
31
KR
5
RoW
143
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Heptares Therapeutics
Top ten assignees appearing on patents
2009 - 2018
| heptares therapeutics | 391 |
| takeda pharmaceutical company | 4 |
| takeda cambridge | 1 |
| heptares therapeutic | 1 |
2009
| heptares therapeutics | 16 |
2018
| heptares therapeutics | 102 |
Heptares Therapeutics
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| mutant g-protein coupled receptors and methods for selecting them | 45 | 2007 |
| 1,2,4-triazine-4-amine derivatives | 37 | 2010 |
| muscarinic m1 receptor agonists | 35 | 2011 |
| bicyclic aza compounds as muscarinic m1 receptor and/or m4 receptor agonists | 29 | 2014 |
| bicyclic aza compounds as muscarinic m1 receptor agonists | 28 | 2012 |
| screening | 22 | 2007 |
| muscarinic receptor agonists | 21 | 2014 |
| 4-(3-cyanophenyl)-6-pyridinylpyrimidine mglu5 modulators | 20 | 2013 |
| muscarinic agonists | 18 | 2015 |
| cgrp receptor antagonists | 16 | 2015 |